Stay updated with breaking news from Generation Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Generation Bio Co. (NASDAQ:GBIO – Get Free Report) has been given an average rating of “Moderate Buy” by the six analysts that are covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price target […]
Avidity Biosciences (NASDAQ:RNA – Get Free Report) and Generation Bio (NASDAQ:GBIO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership. Analyst Recommendations This is a summary of […]
CAMBRIDGE, Mass., Sept. 19, 2023 -- Generation Bio Co. , a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough,...
Shares of Generation Bio Co. (NASDAQ:GBIO – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price […]
Needham & Company LLC reaffirmed their buy rating on shares of Generation Bio (NASDAQ:GBIO – Free Report) in a report published on Thursday, Benzinga reports. They currently have a $14.00 target price on the stock. Separately, Wedbush reissued an outperform rating and issued a $11.00 price objective on shares of Generation Bio in a research […]